Avoid Mishaps During Semaglutide and Tirzepatide Shortages
July 2024
You’ll need to stay alert for med errors caused by shortages of semaglutide (Wegovy) and tirzepatide (Zepbound) for weight loss.
These injectable GLP-1 agonists are the most effective meds for treating overweight or obesity. But supply issues can lead to med changes...which may lead to problems you discover upon admission.
During med histories, clarify home med lists that contain two GLP-1 agonists. Switching to a different product may be a possibility during shortages, which could lead to med lists mistakenly including both.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote